n-vinyl-2-pyrrolidinone has been researched along with Leukemia P388 in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hagiwara, A; Ozaki, K; Sakakura, C; Sasaki, S; Sawai, K; Shimotsuma, M; Shirasu, M; Shobayashi, S; Takahashi, T; Tsujimoto, H | 1 |
1 other study(ies) available for n-vinyl-2-pyrrolidinone and Leukemia P388
| Article | Year |
|---|---|
[Enhancement of therapeutic efficacy of aclarubicin against lymph node metastases using a new dosage form: aclarubicin adsorbed on activated carbon particles].
Topics: Aclarubicin; Animals; Carbon; Drug Delivery Systems; Leukemia P388; Lymphatic Metastasis; Mice; Povidone | 1992 |